Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine (MV-CHIK-202)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02861586
Recruitment Status : Completed
First Posted : August 10, 2016
Last Update Posted : June 21, 2018
Information provided by (Responsible Party):
Themis Bioscience GmbH